Premium
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry
Author(s) -
Inzinger M.,
Heschl B.,
Weger W.,
Hofer A.,
Legat F.J.,
GruberWackernagel A.,
Tilz H.,
Salmhofer W.,
Quehenberger F.,
Wolf P.
Publication year - 2011
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2011.10396.x
Subject(s) - medicine , psoriasis , etanercept , ustekinumab , adalimumab , psoriasis area and severity index , efalizumab , dermatology , puva therapy , infliximab , plaque psoriasis , tumor necrosis factor alpha
Few studies have directly compared the clinical efficacy of psoralen plus ultraviolet A (PUVA) vs. biologics in the treatment of psoriasis.